Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry

Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock

1999 • 2,805 citations

Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction

1995 • 1,093 citations

Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction

1999 • 873 citations

Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK Trial Registry

2000 • 675 citations

Influence of Diabetes on 5-Year Mortality and Morbidity in a Randomized Trial Comparing CABG and PTCA in Patients With Multivessel Disease

1997 • 623 citations

Temporal Trends in Cardiogenic Shock Complicating Acute Myocardial Infarction

1999 • 601 citations

Influence of Diabetes Mellitus on Early and Late Outcome After Percutaneous Transluminal Coronary Angioplasty

1995 • 547 citations

Cardiogenic Shock after Acute Myocardial Infarction

1991 • 481 citations

Coronary Angioplasty in Diabetic Patients

1996 • 454 citations

Current Spectrum of Cardiogenic Shock and Effect of Early Revascularization on Mortality

1995 • 388 citations

Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience

1995 • 382 citations

A composite view of cardiac rupture in the United States national registry of myocardial infarction

1996 • 324 citations

Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: The primary angioplasty in myocardial infarction (PAMI) trial

1995 • 302 citations

Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock.

1988 • 281 citations

Coronary Revascularization in Diabetic Patients

1999 • 272 citations

Influence of diabetes on mortality in acute myocardial infarction: Data from the GISSI-2 study

1993 • 269 citations

Impact of an Aggressive Invasive Catheterization and Revascularization Strategy on Mortality in Patients With Cardiogenic Shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) Trial

1997 • 225 citations

SHould We Emergently Revascularize Occluded Coronaries for Cardiogenic ShocK: An international randomized trial of emergency PTCA/CABG—trial design

1999 • 190 citations

Cardiogenic shock complicating acute myocardial infarction: Predictors of death

1999 • 177 citations

Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction

1992 • 175 citations

Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock

1992 • 148 citations

Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: Incidence, risk factors, and outcome

1993 • 135 citations

Cardiogenic shock complicating acute myocardial infarction: The use of coronary angioplasty and the integration of the new support devices into patient management

1992 • 128 citations

Selection Bias in the Use of Thrombolytic Therapy in Acute Myocardial Infarction

1991 • 128 citations

Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry

2000 • 126 citations

Significance of diabetes mellitus in patients with acute myocardial infraction receiving thrombolytic theraphy

1993 • 117 citations

Diabetic Retinopathy Should Not Be a Contraindication to Thrombolytic Therapy for Acute Myocardial Infarction: Review of Ocular Hemorrhage Incidence and Location in the GUSTO-I Trial fn1fn1This study was supported by Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genentech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.

1997 • 89 citations

Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb angioplasty substudy

2000 • 86 citations

Myocardial infarct size and mortality in patients with non‐insulin‐dependent diabetes mellitus

1994 • 70 citations

Early and 1-year survival rates in acute myocardial infarction complicated by cardiogenic shock: A retrospective study comparing coronary angioplasty with medical treatment

1995 • 66 citations

Limits of reperfusion therapy for immediate cardiogenic shock complicating acute myocardial infarction

1994 • 39 citations

Effectiveness of percutaneous transluminal coronary angioplasty in cardiogenic shock during acute myocardial infarction

1992 • 37 citations

Cardiogenic shock complicating myocardial infarction

1989 • 32 citations

Efficacy of invasive strategy for the management of acute myocardial infarction complicated by cardiogenic shock

1999 • 28 citations